Inc. (NASDAQ: MNMD), (the "Company" or "MindMed"), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced its second ...

Cherry SE announced today that Jurjen Jongma (54) has been appointed Chief Financial Officer by the Supervisory Board with effect from 1 September 2025. Volker Christ, who previously headed the ...